INOZYME

inozyme-logo

Inozyme is a provider of therapies for rare diseases of calcification affecting soft tissues and bone created to offer potentially disease-modifying therapies to help children who are affected with rare, but severe and debilitating disorders of metabolism. The company's enzyme replacement therapy provides the treatment of Generalized Arterial Calcification of Infancy (GACI) and Autosomal Recessive Hypophosphatemic Rickets Type 2 (ARHR2), enabling patients to treat diseases characterized by mineral imbalances in the body.

#SimilarOrganizations #People #Financial #Event #Website #More

INOZYME

Social Links:

Industry:
Biotechnology Health Care Medical Pharmaceutical

Founded:
2016-01-01

Address:
Boston, Massachusetts, United States

Country:
United States

Website Url:
http://www.inozyme.com

Total Employee:
11+

Status:
Active

Contact:
+1 (857) 330-4340

Email Addresses:
[email protected]

Total Funding:
220.1 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics


Similar Organizations

aprea-logo

Aprea

Aprea focuses on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53.

neogenomics-logo

NeoGenomics

NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.

tiburio-therapeutics-logo

Tiburio Therapeutics

Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.

zs-pharma-logo

ZS Pharma

ZS Pharma develops ion trap therapies for the treatment of life-threatening medical conditions such as hyperkalemia and liver diseases.


Current Advisors List

axel-bolte_image

Axel Bolte Board Of Director @ Inozyme
Board_member

david-thompson_image

David Thompson Senior Advisor @ Inozyme
Advisor
2020-10-01

ed-mathers_image

Ed Mathers Board Of Director @ Inozyme
Board_member

joseph-schlessinger_image

Joseph Schlessinger Board Of Director @ Inozyme
Board_member

doug-treco_image

Doug Treco Chairman of the Board @ Inozyme
Board_member
2020-06-01

martin-edwards_image

Martin Edwards Board Of director @ Inozyme
Board_member

reinaldo-m-diaz_image

Reinaldo M. Diaz Board Of director @ Inozyme
Board_member
2016-01-01

Current Employees Featured

not_available_image

Soojin Kim
Soojin Kim Senior vice president and chief technical operations officer (CTOO) @ Inozyme
Senior vice president and chief technical operations officer (CTOO)

stephen-basso_image

Stephen Basso
Stephen Basso Senior Vice President, Finance @ Inozyme
Senior Vice President, Finance

kurt-gunter_image

Kurt Gunter
Kurt Gunter Chief Medical Officer @ Inozyme
Chief Medical Officer
2022-06-01

axel-bolte_image

Axel Bolte
Axel Bolte Co-founder & CEO @ Inozyme
Co-founder & CEO
2017-02-01

not_available_image

Gayle T. Gironda
Gayle T. Gironda Senior Vice President Human Resources @ Inozyme
Senior Vice President Human Resources
2021-07-01

not_available_image

Sanjay Subramanian
Sanjay Subramanian Chief financial officer (CFO) @ Inozyme
Chief financial officer (CFO)

catherine-a-nester_image

Catherine A. Nester
Catherine A. Nester VP of Physician & Patient Strategies @ Inozyme
VP of Physician & Patient Strategies

tara-greene_image

Tara Greene
Tara Greene Vice President of Quality and Compliance @ Inozyme
Vice President of Quality and Compliance

pedro-huertas_image

Pedro Huertas
Pedro Huertas SVP and CMO @ Inozyme
SVP and CMO

eric-yuen_image

Eric Yuen
Eric Yuen CMO @ Inozyme
CMO
2017-01-01

Founder


axel-bolte_image

Axel Bolte

eric-yuen_image

Eric Yuen

steven-jungles_image

Steven Jungles

Stock Details


Company's stock symbol is NASDAQ:INZY

Investors List

k2-healthventures_image

K2 HealthVentures

K2 HealthVentures investment in Post-IPO Debt - Inozyme

cowen-healthcare-investments_image

Cowen Healthcare Investments

Cowen Healthcare Investments investment in Series A - Inozyme

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Series A - Inozyme

pivotal-bioventure-partners_image

Pivotal bioVenture Partners

Pivotal bioVenture Partners investment in Series A - Inozyme

sofinnova-ventures_image

Sofinnova Investments

Sofinnova Investments investment in Series A - Inozyme

sanofi-genzyme-bioventures_image

Sanofi Ventures

Sanofi Ventures investment in Series A - Inozyme

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Series A - Inozyme

rock-springs-capital_image

Rock Springs Capital

Rock Springs Capital investment in Series A - Inozyme

longitude-capital_image

Longitude Capital

Longitude Capital investment in Series A - Inozyme

novo-a-s_image

Novo Holdings

Novo Holdings investment in Series A - Inozyme

Official Site Inspections

http://www.inozyme.com Semrush global rank: 4.29 M Semrush visits lastest month: 2.68 K

  • Host name: 141.193.213.10
  • IP address: 141.193.213.10
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Inozyme" on Search Engine